Neurobiological research on Alzheimer's and dementia

Medical experts are highlighting the biological processes underlying Alzheimer’s disease and dementia, noting that neurobiological changes often begin decades before clinical symptoms appear.

Initial reports emphasize that biological changes can precede cognitive symptoms, such as memory loss or difficulty with routine tasks. Dr. Guido Dorman noted that during these early stages, individuals may maintain social connections and work through cognitive reserve despite underlying neurodegeneration. Alzheimer’s is identified as the most frequent cause of dementia, which affects over 60 million people globally.

Further neurobiological insights clarify the distinction between dementia—a syndrome of progressive cognitive decline—and Alzheimer’s disease. Research indicates that while symptoms typically manifest in a person’s 60s or 70s, biological processes may begin as early as age 30 to 40. While Alzheimer’s accounts for 60% to 70% of dementia cases, vascular dementia follows at 10% to 20%.

Regarding etiology, it is noted that less than 5% of Alzheimer’s cases are caused by dominant hereditary mutations, with over 95% being sporadic. In these cases, lifestyle and environmental factors are critical. Recent findings specify that the neurodegenerative process is driven by the accumulation of amyloid beta and tau proteins, which can affect brain function silently for 15 to 20 years before clinical symptoms become apparent.

Early indicators may manifest as ‘mild cognitive complaints’ rather than overt memory loss, including mental slowing, difficulty finding words, increased mental fatigue, decreased attention spans, and multitasking challenges. Risk factors include genetic predisposition and modifiable lifestyle factors such as hypertension, obesity, diabetes, insulin resistance, sedentary lifestyles, sleep disorders, chronic stress, and smoking.